Home > Financial Ratios > BALAXI PHARMACEUTICALS

BALAXI PHARMACEUTICALS
EV/Core EBITDA

    Back to All Ratios
BALAXI PHARMACEUTICALS is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for BALAXI PHARMACEUTICALS
Please provide your vote to see the results

BALAXI PHARMACEUTICALS Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
   EV/Core EBITDA(x) 10.3010.5610.988.726.24

What is the latest EV/Core EBITDA ratio of BALAXI PHARMACEUTICALS ?

The latest EV/Core EBITDA ratio of BALAXI PHARMACEUTICALS is 10.30 based on Mar2026 Consolidated results.
Year EV/Core EBITDA
Mar202610.30
Mar202510.56
Mar202410.98
Mar20238.72
Mar20226.24

How is EV/Core EBITDA of BALAXI PHARMACEUTICALS Trending?

Years EV/Core EBITDA % Change
Mar2026 10.3
-2.46
Mar2025 10.56
-3.83
Mar2024 10.98
25.92
Mar2023 8.72
39.74
Mar2022 6.24 -

Other Financial Ratios of BALAXI PHARMACEUTICALS


Compare EV/Core EBITDA ratio of peers of BALAXI PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS ₹127.6 Cr -0.9% -3.7% -49.2% Stock Analytics
ADANI ENTERPRISES ₹396,911.0 Cr -0.9% -3.6% 36.4% Stock Analytics
AEGIS LOGISTICS ₹46,458.4 Cr 4.4% 4.6% 92.7% Stock Analytics
ADITYA INFOTECH ₹43,295.0 Cr -4.4% 4% 184.7% Stock Analytics
PREMIER ENERGIES ₹42,989.2 Cr -4.1% -6.8% -2.4% Stock Analytics
REDINGTON ₹29,566.7 Cr 1.2% 13.4% 61.9% Stock Analytics


BALAXI PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS

-0.9%

-3.7%

-49.2%

SENSEX

-2.8%

-5.2%

-8.4%


You may also like the below Video Courses